Phase III Efficacy and Safety Data for Oral Ozanimod in Relapsing Multiple Sclerosis to Be Presented at MSParis2017 7th Joint ECTRIMS ACTRIMS Meeting

Ozanimod highlighted in two oral presentations detailing results from phase III SUNBEAM and RADIANCE trials in RMS Additional clinical and nonclinical poster presentations will further characterize the profile of ozanim...